Detalhe da pesquisa
1.
[The circulating PD-L1: An emerging predictive biomarker for immune checkpoint inhibitors response]. / Le taux circulant de PD-L1 : un biomarqueur émergent de réponse aux inhibiteurs de checkpoints immunitaires.
Bull Cancer
; 111(4): 416-427, 2024 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-38438284